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Burn injury is one of the challenging cases in medi-
cal practice, which need comprehensive and multi-
discipline management. Teamwork is the essence of 
burn injury management. No individual is capable of 
fulfilling the acute and long-term needs of the burn 
patient. Physicians, nurses, nutritionists, psycholo-
gists, physical therapists, and social workers can all 
participate as a team in the burn care. Burn injury 
management is best performed in the burn center.
Many aspects must be concerned in burn 
care, including evaluation of burn patients, initial 
management, fluid resuscitation, nutrition, the risk 
of infection, pain control, surgical management, 
wound care, and long-term care. Pain management 
is one of an important factors in caring for the burn 
patient. Pain management in burn injury is chal-
lenging and the patient may be at risk for under-
treatment. Undertreated severe acute pain can lead 
to adverse consequences of many organ systems, 
delay recovery and discharge process, and poten-
tially lead to chronic pain. Reports of inadequate 
pain relief persist, although there are advances in 
the acute pain management in recent years.1-5 This 
review aims to provide a basic understanding of 
burn injury pain mechanism, type, and treatment. 
The Depth of Burn Injury and Correlation to 
Pain
The depth of burn injury can be categorized into 
four degrees. First or superficial burn involves the 
epidermis only, erythematous, and painful. Second 
or partial thickness burn involves the entirety of the 
epidermis and a portion of the dermis. Based on 
the depth of dermal injury, partial thickness burns 
are further divided into superficial and deep partial 
thickness. Superficial partial thickness burns are 
typically pink, moist, and painful to the touch. Deep 
partial thickness burns are typically dry, mottled 
pink and white, and have variable sensation. Third 
or full thickness burns involve the epidermis and 
the entirety of the dermis, brown-black, leathery, 
and little or no pain.4 
As described above, depth of burn injury deter-
mines the degree of burn injury pain. The most 
painful burn injury pain is first or superficial burn 
injury, followed by second or partial thickness burn 
injury. Third or full thickness burn injury associ-
ated with little or no pain. In addition to the depth 
of burn injury, the extent of burn also determines 
the degree of burn injury pain. 
Mechanism of Burn Injury Pain
Mechanism of burn injury pain is complex, 
involving both peripheral and central processes. 
It combines features of nociceptive, inflammatory, 
and neuropathic burn injury pain. However, burn 
injury pain is subjective and different from each 
other by etiology, the depth, and extent of burn 
injury.3,6 
Nociceptive pain. Initial burn injury pain is 
somatic nociceptive pain. Somatic nociceptive pain 
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An understanding of pain pathway can achieve effective burn 
injury pain management, types of pain in burn injury, analgesics 
selection, continuous and accurate assessment of the pain and the 
response to therapy, dose adjustment to achieve maximum effect 
and minimal side effect, and role of nonpharmacological treatment as 
a complement to medication. Acute pain service plays an important 
role in providing effective burn injury pain management for reducing 
morbidity and mortality.
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is well-localized and usually described as a sharp, 
aching, tearing, or throbbing pain. Nociceptive 
pain ends when there is no more noxious stimulus 
on sensory nerve endings.5,6
Damaged tissue or potentially damaging 
(noxious) stimulus will stimulate sensory nerve 
endings called nociceptor. Nociceptor can be found 
in the soft tissue such as skin, subcutaneous tissue 
and muscles (somatic nociceptor), and in the 
viscera (visceral nociceptor). Nociceptors are the 
peripheral endings of A-delta (Aδ) and C sensory 
fibers.5,6
Noxious stimuli are transduced into an electrical 
signal by nociceptors and transmitted to secondary 
afferent neurons in the dorsal horn of the spinal 
cord. There are complex interactions between affer-
ent neurons, interneurons and descending modu-
latory (inhibition) pathways in the dorsal horn. 
Second-order neurons, the spinothalamic tract and 
spinoreticular tract transmit a nociceptive signal 
to higher centers in the brain, i.e. thalamus, retic-
ular formation, nucleus raphe magnus, and peri-
aqueductal grey matter. Third-order neurons send 
signals to the somatosensory area I in postcentral 
gyrus and somatosensory area II in superior wall of 
Sylvian fissure. These brain cortices are responsible 
for perception and localization of pain.5,6 
Inflammatory pain. Acute inflammatory response 
to burn injury causes inflammatory-triggered burn 
injury pain. The inflammatory response can be 
restricted to the site of injury or involve systemic 
processes, which can affect multiple organs 
and associated with significant morbidity and 
mortality.3,7 
Activation of damage associated molecular 
pattern (DAMP) receptors and local ischemia or 
reperfusion injury in burn patients will lead to acti-
vation of the alternative complement pathway, the 
release of histamine, bradykinin, pro-inflammatory 
cytokine (TNF-a, IL-1b, IL-6), catecholamines, 
oxygen free radicals, nitric oxide, arachidonic acid 
cascade products, and the activation and recruit-
ment of leukocytes.3,7-9 
Released inflammatory and chemical mediators, 
vascular damage due to histamine release, and isch-
emia will generate sensitization and excitation of 
nociceptors, evoke sensitization of central neurons 
as a result of sustained nociceptive stimulation 
during and after injury. Inflammatory mediators 
and cytokine have a role in burn-induced allodynia 
and hyperalgesia.3,7-9
Neuropathic pain. Neuropathic pain may be 
caused by a combination of the peripheral, central 
and psychological mechanism. Damage of somato-
sensory system in burn injury lead to acute and 
chronic neuropathic pain. This damage generates 
ectopic firing and other pathological processes. 
Patients often describe the sensation of burning, 
pins and needles, shooting, stabbing sensations. 
There may be hyperalgesia (an increased pain to 
a painful stimulus) and allodynia (pain due to a 
normally innocuous stimulus). Neuropathic pain 
after burn injury could be exacerbated by light 
touch, dependent position, temperature change, 
and weight-bearing activities.3,10,11
Peripheral mechanisms of neuropathic pain 
include spontaneous firing, sensitization of noci-
ceptor to stimuli, and up-regulation of an adren-
ergic receptor. Central mechanism apparently 
plays a major role in neuropathic pain. There are 
several phenomena involved in central sensitiza-
tion including wind-up of wide dynamic range 
(WDR) neurons, microglial activation in the 
spinal cord, spinal sensitization by activation of the 
N-methyl-D-aspartate (NDA) glutamate receptor, 
loss of segmental inhibition, and reorganization 
of neural connections. The systemic activation of 
DAMP receptors, direct effects of C5a and a pro-in-
flammatory cytokine, causing increased blood-
brain barrier permeability and may lead to central 
inflammation.3,6 
Type of Burn Injury Pain
•	 Initial	 burn	 injury	 pain	 is	 nociceptive	 pain,	
immediate, severe, and regressive. It ends 
when there is no more noxious stimulus.
•	 Background	burn	injury	pain	is	inflammatory	
pain, present on a daily basis, slightly varied 
between procedures, and prolonged until the 
wound healed.
•	 Procedural	 burn	 injury	 pain	 is	 nociceptive	
pain, immediate, severe, and repetitive, short 
to medium duration, which occurs during 
daily wound care (dressing changes), bath, 
and physiotherapy. 
•	 Acute	neuropathic	burn	injury	pain	is	neuro-
pathic pain during healing period. 
•	 Chronic	burn	injury	pain	following	healing	of	
a burn injury. It may occur with an incidence 
of 25-36% and correlated with the severity of 
initial burn injury. 
•	 Breakthrough	burn	injury	pain	is	episodes	of	
intense and sudden pain during rest. It may 
occur during or following healing period, 
with or without a trigger.3,4,12,13 
Burn Injury Pain Treatment
Burn injury pain management is done to facilitate 
the effective and safe pain management, reduce 
the risk of complication or side effect, main-
tain the patient’s functional abilities (includes 
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physical and psychologic), and enhance the quality 
of the patient’s life. It involves pharmacological and 
nonpharmacological treatment. 
The World Federation of Societies of 
Anesthesiologists (WFSA) has developed descending 
analgesic ladder to treat acute pain. This concept can 
be used in the management of acute burn injury pain. 
Initial severe acute burn injury pain is treated with a 
strong opioid, regional analgesia using local anesthetic, 
and peripherally acting drugs. Acute burn injury pain 
should decrease with time, the need of injection to 
deliver analgesic should cease and weak oral opioid 
can be established. The second rung involves the use 
of a combination of weak oral opioid and peripher-
ally acting drugs. The final step, pain controlled by 
peripherally acting drugs alone, including aspirin and 
nonsteroidal anti-inflammatory drugs (NSAIDs).14,15
The key to successful pharmacological treat-
ment is the concept of multimodal analgesia which 
utilizes the dose adjustment to achieve maximum 
effect and decrease the risk of adverse reaction; 
and the continuous and accurate assessment of the 
patient’s pain and the response to therapy.5,16,17
Nonpharmacological treatment is complemen-
tary to medication to control pain in burn injury 
patients. Its role cannot be underestimated. The 
treatment involves several disciplines, including 
psychologists, psychotherapists, physiotherapists, 
and pain specialists. It begins as early as possible 
to control the development of anxiety, which can 
aggravate pain.3,16,17
Initial burn injury pain. Initial burn injury pain 
is nociceptive pain. It can be reduced by cooling 
the burn. Strong and shorter acting analgesics are 
probably best for injury burn injury pain regarding 
its nature. Initial severe acute burn injury pain is 
treated with a strong opioid, regional analgesia 
using local anesthetics, and peripherally acting 
drugs. The drug options are similar to procedural 
burn injury pain as described later.16 
Background burn injury pain. Background burn 
injury pain is inflammatory pain that continues 
while patients at rest. This type of pain is best treated 
with longer-acting agents. Based on the pathophys-
iology of background burn injury pain, regular 
evaluation and titration of multimodal analgesia 
are recommended. Combination of long-acting 
opioid, NSAIDs, acetaminophen (paracetamol), or 
ketamine infusion can be used.3,4,16
Intravenous opioid infusion, with or without 
patient-controlled analgesia (PCA), oral metha-
done, or oral prolonged released opioids (morphine 
or oxycodone) are opioids suitable for management 
of background burn injury pain. Methadone has a 
half-life of 6 hours and requires a taper to discon-
tinuation. Opioids adverse effects are well-known, 
particularly sedation, respiratory depression, 
nausea, vomiting, itching, and constipation. 
Prolonged use of opioids increases the risk of toler-
ance or opioid-induced hyperalgesia. Tolerance 
will lead to increased dose requirement over time 
to achieve the same level of analgesia. Consider 
opioid-induced hyperalgesia if pain poorly 
controlled and worsen during opioid treatment.4,17
NSAIDs may reduce the dose of opiates needed 
by up to 20-30%, therefore may also reduce the 
adverse effects of opioids. NSAIDs act synergisti-
cally with opioids, but weak if used alone. NSAIDs 
can be classified by its action on the cyclooxygenase 
(COX) enzymes and chemical structure as tradi-
tional, nonselective COX inhibitors or selective 
COX-2 inhibitors. NSAIDs inhibit the formation of 
prostaglandins. COX-1 inhibition will lead to gastric 
ulcer and inhibition of platelet aggregation. Selective 
COX-2 inhibitors cause less bleeding and fewer 
ulcers than nonselective NSAIDs because it has 
little effect on COX-1. NSAIDs, especially selective 
COX-2 inhibitors associated with an increased risk 
of cardiovascular events. Severe burn injury, surgical 
excision, and grafting are at risk of bleeding.4,16,17
Paracetamol is an antipyretic and analgesic. The 
exact mechanism of action of paracetamol remains 
to be determined and is likely to involve several 
pain pathways, including effects on prostaglandin 
production, and on serotonergic, opioid, nitric oxide 
(NO), and cannabinoid pathways. Paracetamol is 
generally considered to have opioid-sparing effects 
(reduction in opioid consumption). Hepatotoxicity 
may occur with doses within the therapeutic range 
in patients with glutathione deficiencies, inadequate 
nutrition, P450 enzyme induction by chronic alco-
hol excess, or concomitant use of other drugs.17,18
Ketamine has been demonstrated to be an 
NMDA receptor antagonist, which may reduce 
central sensitization. Use of ketamine is limited by 
its psychotomimetic effects, including delirium, 
agitation, and hallucinations. Even subanesthetic 
dose of ketamine may cause hallucination. The inci-
dence of psychomimetic symptoms is much lower 
in children than in adults. Co-administration with 
a benzodiazepine can reduce these effects.3,4
Procedural burn injury pain. Procedural burn 
injury pain is nociceptive pain. Strong and shorter 
acting analgesics are recommended for procedural 
burn injury pain. Procedural burn injury pain 
can be managed by combinations of short-acting 
opioids, subanesthetic doses of nitrous oxide/
oxygen, ketamine, an alpha-2 agonist, or benzodi-
azepines. Nonpharmacological treatment includes 
hypnosis and virtual reality can be used while 
undergoing procedural interventions. Pain during 
rehabilitation can be relieved by relaxation, distrac-
tion, and cognitive-behavioral therapy.3,4,16,17
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A short-acting parenteral opioid is the drug of 
choice in procedural burn injury pain. Morphine, 
fentanyl, or oxycodone can be used. Remifentanil 
has an ultra-rapid onset of action and plasma 
metabolism. Remifentanil is administered as a 
continuous infusion during procedures. Fentanyl 
and alfentanil give an advantage of residual anal-
gesia. The physician should be alert to the risk 
of sedation, respiratory depression, nausea, and 
vomiting.3,17
Nitrous oxide is an inhaled anesthetic with anal-
gesic properties. Combination of inhaled nitrous 
oxide and oxygen can be used for short procedures 
as it has a rapid onset (within seconds) and short 
duration of action. Nitrous oxide may cause nausea 
and vomiting. Chronic use of nitrous oxide may 
lead to blood dyscrasias and neurological deficits 
due to inactivation of vitamin B12.3
Ketamine is an intravenous anesthetic with 
potent analgesic effects at subanesthetic doses. The 
intravenous or intramuscular administration is 
generally selected for procedural burn injury pain, 
with a fast onset of action (1–5 minutes) and short 
duration of action (10–30 minutes). It induces a 
dissociative state, where patients appear conscious 
(e.g. eye-opening, swallowing) but unable to 
respond to sensory input. Rapid intravenous bolus 
administration or combination with opioids may 
produce apnea. The anticholinergic agent can be 
used to reduce hypersalivation associated with 
ketamine. Upon recovery, patients can experience 
psychotomimetic effects. Deep conscious sedation 
can be achieved by combination of ketamine with 
propofol or midazolam.3,17 
Alpha-2 agonists is an analgesic by stim-
ulating the descending inhibitory pain path-
ways. They have sedative and antihypertensive 
effects. Dexmedetomidine is a highly selective 
 α2-adrenoceptor agonist. It is eight times more 
selective for the α2-adrenoceptor than clonidine. 
Dexmedetomidine has a shorter duration of action 
than clonidine. Hypotension and bradycardia 
are the most common adverse effects of alpha-2 
agonist.17
Benzodiazepine is an anesthetic agent and not 
considered analgesic. It can relieve pain in combi-
nation with other analgesics, most likely due to 
their sedative, hypnotic, and anxiolytic effects. 
Anxiety can cause decreased pain tolerance and 
exacerbate pain symptoms. Midazolam is the most 
commonly used due to the rapid onset of action and 
relatively rapid recovery. Diazepam and lorazepam 
have prolonged the context-sensitive half-time. 
Benzodiazepines have synergistic sedative effect 
with another central nervous system depressant 
including opioids, intravenous anesthetics, and 
alpha-2 agonists.3,4,17
Hypnosis is an altered state of consciousness. It is 
characterized by increased receptivity to suggestion, 
ability to change perceptions and sensations, and 
increased capacity for dissociation. Virtual reality 
is a method of distraction. The technology isolates 
the patients from the real world. The patients are 
actively engaged in another task in a virtual environ-
ment while undergoing procedural interventions.3,17
Acute neuropathic burn injury pain. Neuropathic 
burn injury pain can occur acutely. It can present 
only at the time of injury and may become chronic 
following healing of the burn injury. This phenom-
enon correlates with extensive damage to cutane-
ous nociceptors and conducting nerve fibers in 
burn wound. Pregabalin is effective to relieve acute 
neuropathic symptoms. Some burn centers use 
tricyclic antidepressants and other anticonvulsants. 
Tramadol and opioids also promote a beneficial 
effect in neuropathic pain.3,17
Chronic burn injury pain. Basic principles of 
chronic pain management should be applied 
including multimodal analgesia, nonphar-
macological treatment, and multidisciplinary 
team. Chronic neuropathic burn injury pain 
is difficult to treat using conventional analge-
sics. Pregabalin, gabapentin, antidepressant, 
and steroid injection are reportedly effective in 
some patients with neuropathic pain symptoms. 
Nonpharmacologic treatment by rest, elevation, 
compression garment use, and massage may 
reduce pain symptoms.3,11,16
Pregabalin and gabapentin are anticonvulsant. 
Anticonvulsant acts by blocking voltage-gated 
calcium or sodium channel and suppress spon-
taneous neural firing, thus diminish the central 
sensitization in chronic pain. Pregabalin was 
well-tolerated and significantly reducing neuro-
pathic pain in burn injury patients.6,17
Antidepressants demonstrate an analgesic effect 
at a dose lower than required for the antidepres-
sant effect. They activate the descending inhibitory 
pathways in the spinal cord. Antidepressants poten-
tiate the opioids action. Low dose amitriptyline is 
useful to relieve chronic burn injury pain. Selective 
serotonin reuptake inhibitors may also be used 
as an alternative to a tricyclic antidepressant. The 
analgesic effect of antidepressants usually occurs 
within days or weeks.6,17
Breakthrough pain. It can happen during or 
following healing period can be treated by “rescue 
medication.” The analgesic used is working fast and 
lasts for a short period. Severe breakthrough pain is 
commonly treated with a short-acting opioid that 
is 5-20 percent of total daily opioid dose to manage 
chronic pain.3,16,17 
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Acute Pain Service
Acute pain service (APS) is an organization in the 
hospital, dedicated to the management of acute 
pain including in perioperative setting, parturi-
ent, trauma, acute medical condition, and other 
patients with acute pain. The APS has the respon-
sibility for 24h pain management including regu-
lar pain assessment, adjustable pain management 
delivery, complications or side effects assessment 
and management, documentation of records, audits 
and defined performance criteria for evaluation. 
The APS also has an important role to ensure the 
safety of the techniques, continuous professional 
development, provides in-house training programs 
for medical and nursing staff about the identifica-
tion and management of complications, patient 
education about pain and treatment options, 
committed to audits of the efficacy of the methods 
and cost-effectiveness.5,19,20 
The APS has a lot of treatment and technique 
modalities, from pharmacological, interventional, 
and nonpharmacological methods. Pharmacological 
modalities by using opiates, NSAIDs, aspirin or 
acetaminophen and adjuvants. Various technique 
can be used including patient-controlled analge-
sia (PCA), epidural or intrathecal analgesia, and 
peripheral nerve blocks.5,19,20
The characteristic of APS as described above are 
suitable for burn injury pain management. The APS 
plays an important role in the success of burn injury 
pain management using various treatment and 
technique modalities, regular pain assessment and 
response to therapy, continuous analgesics adjust-
ment, assessment and management of complication 
or side effect.
CONCLUSION
Pain management in burn injury is challenging. An 
understanding of pain pathway can achieve effec-
tive burn injury pain management, types of pain in 
burn injury, analgesics selection, continuous and 
accurate assessment of the pain and the response 
to therapy, dose adjustment to achieve maximum 
effect and minimal side effect, and role of nonphar-
macological treatment as a complement to medica-
tion. Acute pain service plays an important role in 
providing effective burn injury pain management 
for reducing morbidity and mortality.
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